Litcius/Paper detail

Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review

Sebastião N. Martins-Filho, Juan Putra

2020Hepatic Oncology54 citationsDOIOpen Access PDF

Abstract

This review highlights two rare entities that are predominantly seen in children: hepatic mesenchymal hamartoma (HMH) and undifferentiated embryonal sarcoma of the liver (UESL). HMH is a benign lesion predominantly seen in the first 2 years of life, while UESL is malignant and usually identified in patients between 6 and 10 years of age. UESL may arise in the background of HMH, and the association has been supported by similar chromosomal aberrations (19q13.4). The diagnosis of both lesions is primarily based on histologic evaluation, as the clinical and radiological features are not always typical. The clinicopathologic characteristics, pathogenesis, differential diagnoses and treatment for both lesions are discussed.

Topics & Concepts

MedicineHamartomaPathologyDifferential diagnosisSarcomaMesenchymal stem cellHistopathologyCholangiocarcinoma and Gallbladder Cancer StudiesSarcoma Diagnosis and TreatmentHistiocytic Disorders and Treatments
Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review | Litcius